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 2 
Introduction  
 
The gold standard measure of surgeon performance for radical prostatectomy would 
include patient reported outcomes such as continence, quality of life with PSA follow 
ups, however this is rarely practical in the clinical setting. There is therefore a need 
for a more easily attainable, unbiased marker of surgical performance. We recently 
showed that T2 positive margin rate is the most informative quality outcome measure 
with the least potential observer bias (1). This highlights the possible use of T2 
positive margin rates as a single objective outcome measure indicative of surgeon 
skill. Positive surgical margins (PSMs) have been studied in depth to analyse their 
clinical implications following radical prostatectomy (RP). Stephenson et al. 
conducted a study looking at 11,521 patients who underwent a RP between 1987 
and 2005 and found no association between margin status and cancer specific 
mortality within 15 years post RP. However, they did observe a positive association 
with biochemical recurrence, so that it is recommended to avoid PSMs where 
possible (2).  
 
Intra-prostatic incision (IPI) is associated with significantly increased bichoemical 
recurrence (BCR), compared to patients with negative surgical margins with or 
without extra-prostatic extension. The 5-year biochemical recurrence-free survival 
was only 77% for patients with intra-prostatic incision, compared to 94% for those 
without (P=<0.0001), according to Preston et al. (3). Similar results have also been 
shown in other studies (4, 5). There is thus a growing body of evidence to support 
PSMs as a prognostic factor indicative of biochemical recurrence following RP.  
 
In addition to its value as a diagnostic predictor, PSM have been suggested to be a 
good indicator of surgeons’ performance. Vickers et al. showed that surgeons who 
performed higher volumes of RP showed a decrease in PSMs over time, with a 
plateau after 250 procedures – suggesting that PSM rates can be used to monitor 
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surgeons’ experience (6). Although this data was published for the open procedure, 
laparoscopic procedures have a similar learning curve as shown by   
Secin et al., who showed a similar learning curve plateauing after 200 to 250 cases 
(7). Whilst pathological factors have been shown to influence margin status, surgeon 
skill and experience also may play an important role. Eastham et al. showed that 
high volume surgeons had significantly lower PSM rates (8). It has been suggested 
that intra-prostatic incision may be a better quality measure of surgeon experience 
than PSM rates (9). However, rates of intra-prostatic incisions vary greatly between 
studies. This is potentially due to the difficulty in differentiating between true T2 
positive margins and extra prostatic extension. (9-11).  
We have therefore evaluated the clinical variables that may affect T2 PSMs to 
determine whether this can be used as an objective measurement of surgeon skill 
and experience. 
 
Methodology 
Study population 
We obtained prospective data for 183 consecutive patients who underwent 
laparoscopic radical prostatectomy (LRP) between 2003 and 2009. A single surgeon 
carried out all procedures. The surgeon reported all data pre, peri and post-
operatively. All data was also verified in the electronic medical records. Only patients 
with T2 stage disease as classified by TNM staging (12) were included in the study.  
 
Margin Status 
Information on margin status was collected post-operatively. A PSM was reported 
when cancer cells were seen touching or extending beyond the inked resection 
margin, and were all identified in one Pathology Department by 10 different 
consultant pathologists, using standard procedures. PSM location was described as 
apical, circumferential or both. The pathologists are all dedicated consultant 
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uropathologists employed in a teaching hospital. Inter-pathologist review of 
specimens is carried out as part of an internal-audit.  
 
Clinical variables 
Pre-operative, peri-operative, and post-operative variables were studied in relation to 
margin status.   
Pre-operative variables included age at surgery, ethnicity, Gleason Score (primary 
and secondary), TNM staging, PSA, and percentage positive cores. Age at surgery 
was categorised into ≤60 and >60 as older age is an important clinical determinant of 
prostate cancer (13). Total Gleason score was divided into three categories (≤6, 7, 
≥8) (14), which corresponded to different survival profiles (15). PSA was divided into 
categories of ≤10 and >10 ng/ml. The percentage of positive cores was studied as a 
categorical variable (<25%, 25-49%, ≥50%). Date of surgery was studied as a 
categorical variable (2003-2004, 2005-2006, 2007-2009), as a measure of increasing 
surgeon experience. 
 
Peri-operative variables were reported by the surgeon and included operative time, 
blood loss and neurovascular bundle (NVB) resection status. NVB status was 
assessed as no NVB, unilateral and bilateral NVB. Operative time (minutes) was 
measured as the time from the first incision to the last suture. Blood loss (ml) was 
recorded from the suction system in theatre.  
 
Post-operative variables studied included prostate weight as reported by the 
pathologists. Length of hospital stay (days) obtained from the medical record.  
 
Statistical Analysis 
Statistical analysis was carried out using Statistical Analysis Systems (SAS) release 
9.4 (SAS Institute, Cary, NC).  
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Univariable logistic regression analysis was performed for each clinical variable to 
assess their associations with margin status. A test for trend was conducted by 
assigning categories as an ordinal scale. To further assess this association while 
adjusting for potential confounding factors, multivariable analysis was performed by 
incorporating all clinical variables in the model. Finally, to assess any differences by 
margin location only in patients with PSM (n=30), one-way ANOVA and Chi2 tests 
were performed for each clinical variable with respect to the three margin locations 
(apical, circumferential or both). 
 
Results  
Descriptive statistics of the patient cohort for pre-operative variables are presented in 
Table 1, with peri and post-operative variables in Table 2. 53% of patients were >60 
years of age at time of surgery. The majority was of a white background and 
presented with PSA ≤10 ng/ml (77%), with a Gleason score of ≤6 (60%). NVB 
resection was performed unilaterally in 29 patients (16%) and bilaterally in 68 (37%).  
Mean hospital stay was 2 days. 49.7% of procedures were carried out between 
2007-2009, when the surgeon was more experienced.  
 
Surgical stage showed a statistically significant correlation with PSM status in both 
univariate (P=0.035) (Table 3) and multivariate analysis (P=0.004) (Table 4). Patients 
with higher surgical stage of T2b and T2c were more likely to have PSMs (OR=8.7 
(95%CI: 1.07-70.71) and OR=4.1 (95%CI: 0.52-33.27), respectively) than those with 
T2a disease. Earlier date of surgery was statistically significantly associated with 
higher PSM rates in both univariate (Table 3) and multivariate analysis (Table 4) (P= 
0.018). PSMs were also most prevalent in patients with prostatic weight between 20-
59g. PSMs were not associated with the reporting pathologist (P-0.855). 
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In contrast with the univariate analysis, larger prostatic weight  (>100g) showed a 
higher predictive value for PSM in multivariate analysis (Table 4). Multivariable 
analysis also showed NVB resection status to be associated with PSMs, with more 
PSM in patients in whom NVB resection was not attempted (P=0.037).  
 
Finally, we assessed whether any of the clinical variables studied were differentially 
distributed across PSM locations (Table 5).  Highest mean blood loss was observed 
in multifocal PSMs (apex and circumferential) (883.3ml, P=0.006). Patients with 
apical PSMs mostly had T2c disease, whereas those with circumferential PSMs had 
the highest proportion of T2b disease (P=0.01).  
 
Discussion 
 
Our multivariate analyses showed that several clinical variables are predictive of T2 
PSMs, including nerve-sparing status and tumour characteristics. Fewer PSM were 
seen with later date of surgery, confirming the notion of a surgical learning curve in 
RP procedures. The reporting pathologist and Gleason score were not associated 
with T2 positive margin status. 
 
PSMs have been extensively studied to determine their clinical significance. Several 
studies have outlined the prognostic value of PSMs (2, 10, 16-20). It is clear that 
while PSMs are not strongly linked to cancer-specific survival, PSMs are an 
important predictor of BCR. For these reasons, PSM rates are increasingly being 
reported as a quality measure, indicating superior surgeon experience and skill. 
However, few studies to date have investigated factors that may influence margin 
status apart from surgical experience and tumour characteristics. Although we 
limited our analysis to patients with pT2 stage, we assessed several clinical variables 
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predictive of prostate cancer prognosis including, pre-operative PSA and Gleason 
score.  
 
Surgeon experience has a large impact on PSM rate. Vickers et al. showed that PSM 
rates were significantly improved when treated by a surgeon who had completed at 
least 250 procedures compared to a surgeon who had completed only 10 (21). Our 
study has also shown this to be the case. Patients who underwent a RP between 
2007 and 2009 had a lower PSM rate, compared to those in 2005-2006 (OR=0.312 
vrs OR=0.417). This was also true of patients undergoing surgery in 2005-2006 
compared to those in 2003-2004 (OR=0.417 vrs OR=1). The British Association of 
Urological Surgeons (BAUS) recently published surgeon reported data regarding 
transfusion, length of stay and complication rates across the UK but positive margin 
rates were not published (22). The current study includes margin data and shows a 
clear link between surgeon experience and positive margin rates T2 disease. The 
surgeon in our study has had extensive training for the laparoscopic procedure. He 
undertook some assiting as a trainee and did part procedure cases as a primary 
surgeon. In addition he underwent 7 months of fellowship training in Institute 
Montsouris, Paris which involved assisting, and gaining dry and wet lab training.  
 
Our study only included T2 disease, and therefore looked at the impact of surgical 
stage on PSMs on a finer basis. We showed a significant association between T2 
PSMs and surgical stage between subclasses in T2 disease (T2 a, b and c). 
Increasing tumour volume makes incision of the prostate more likely in T2 disease. 
Lower prostatic weight has also been shown to be an independent predictor of IPI 
due to the surgical difficulty involved in removing a small gland. (9, 23-25). Marchetti 
et al. (2011) found that predicted probability of a PSM was 22% for patients with 
<25g prostates, which decreased to just 1% for those with >150g prostates (25). Our 
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study also showed lower prostatic weight (20-59g) to be a predictor of T2 PSMs in 
the univariate analysis. In multivariate analysis prostates >100g had highest PSM 
rates. Patients with large prostates constituted a small number of more difficult cases 
and hence resulted in higher positive margin rates. Higher blood loss was associated 
with multifocal PSMs (P=0.006). Higher blood loss is a surrogate for surgical difficulty 
and hence makes surgical incision of the prostate more likely.  
 
PSMs have also been associated with nerve sparing status. Due to the close 
approximation of the NVBs to the postero-lateral prostate gland, this is the most 
common site for iatrogenic IPI (4, 5, 9, 10, 26). Here, NVB status was not associated 
with margin location in the multivariable analysis, contradicting the literature (27). 
Patients who did not undergo NVB sparing procedures had higher incidence of PSMs 
than those with nerve sparing procedures. Non-nerve sparing surgery was more 
likely in high volume T2 disease. High volume disease in the non-nerve spare group 
makes prostatic incision more likely (apex and base) and can explain why higher 
PSM rates were seen in this group of patients. A limit to our study was that 
information on the grade of nerve spare (partial, inter-fascial, intra-fascial) was not 
available as this may have an impact on the risk of PSMs.  
 
IPI refers to iatrogenic incision into the prostate that contains cancer. There is great 
variability in the rates of IPI reported by different studies. For example, several 
studies have found incidence of IPI to be 1.8%-2.8% (9) (11, 28). However, some 
studies have reported rates of IPI as high as 20% (29). Indeed, in our study, 30 
patients (16.4%) presented with PSMs in T2 disease (IPI). One possible explanation 
is difficulty in pathologic interpretation of surgical margin status, as has been 
highlighted by a number of studies (9-11). There is a recognised danger for over-
calling PSMs because of difficulty in differentiating between extraprostatic extension 
(EPE) and IPI (10). Despite recently published guidelines on standardised handling 
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of RP specimens by the International Society of Urological Pathology (ISUP) (2009) 
there is still a lack of consistency in the reporting of surgical margins (30).   
 
A study by van der Kwast et al.(31) highlights the inter-observer variation in the 
reporting of positive margin status. External review of pathology reports was carried 
out for patients in the European Organisation for Research and Treatment of Cancer 
trial (EORTC). There was only a 57.5% agreement for extra-prostatic extension, and 
69.4% concordance for surgical margin status. A total of 24.9% of the cases that 
were called positive at the local hospital were subsequently called negative on review 
in the study. More recent evidence has contradicted these findings, showing 
agreement in over 87% of cases regarding margin status (32) 
. This evidence supports the fact that pathologists may interpret PSMs differently and 
calls into question the objectivity of surgical margin status as a quality measure. 
However in our study, we found no such correlation between the reporting 
pathologist and margin status in both univariate and multivariate analysis. Therefore, 
it seems unlikely that the reporting pathologist has an impact on T2 PSM rates 
reported by different surgeons. It is more likely that, any differences between T2 
PSM rates reported by different surgeons, are down to surgical experience, and 
tumour characteristics, not external bias.  
 
One of the particular strengths of this study was the use of data from a single 
surgeon. This removes the heterogeneity of surgeon skills, and allows valid 
comparisons of PSM rate over time. Only 30 PSMs were present in our study, and 
therefore reduced the statistical power of our analysis. However, our PSM rate was 
comparable with other studies of a similar nature, for example Kumano et al. (2009), 
suggesting that the population was representative (29). Another limitation of the 
current study was that data was missing for many of the patients in our database. 
This was particularly the case for nerve sparing status. In our study, 48 patients 
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(26.2%) were missing data on nerve sparing status. Of these 6 had a PSM at 
surgery, which represents 20% of the PSMs in our population. This may be one 
reason why our study contradicted the majority of the literature with regard to the 
association of NVB resection and PSMs. Time to surgery was not evaluated in our 
cohort and would be interesting to study in the future, as waiting time may lead to 
tumour growth and therefore higher risk of PSM than is predicted by the clinical 
variables.  
 
Conclusion 
In the absence of good patient reported outcomes, T2 positive margin rates are 
increasingly being used a quality outcome measure of surgeon experience. Our 
study has shown that T2 positive margin rates are not influenced by external biases 
such as the reporting pathologist but are affected by tumour characteristics and 
surgeon skill alone and can therefore be considered as an objective measure of 
surgeon skill.  
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Table 1.  
 Frequency/Mean %/SD 
Pre-operative variables   
Age at surgery (yrs)   
≤60 86 47.3 
>60 96 52.7 
Date of Surgery   
2003-2004 44 24.0 
2005-2006 48 26.2 
2007-2009 91 49.7 
Ethnicity    
Black 37 20.2 
White 134 73.2 
Other  3 1.6 
Missing 9 4.9 
PSA (ng/ml)    
≤10 141 77.0 
>10 40 21.9 
Missing 2 1.3 
Percentage cores positive (%)    
<25% 55 30.1 
25-49% 56 30.1 
≥50% 38 20.8 
Missing 34 18.6 
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Table 2. 
Peri-operative variables   
Mean Blood Loss (ml)  279 225 
Mean operative time (mins)  159 37 
Nerve sparing status    
None 38 20.8 
Unilateral 29 15.8 
Bilateral 68 37.2 
Missing  48 26.2 
Post-operative variables   
Mean Hospital stay (days)  2 2.12 
Prostate Weight (g)    
20-59 100 54.6 
60-99 49 26.8 
≥100 13 7.1 
Missing 21 11.5 
Pathologist    
1 67 36.6 
2 7 3.8 
3 10 5.5 
4 53 29 
5 9 4.9 
6 1 0.5 
7 11 6.0 
8 1 0.5 
9 5 2.7 
10 4 2.2 
Missing 15 8.2 
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Surgical Stage   
T2a 30 16.4 
T2b 52            28.4 
T2c 96 52.5 
T2x 5 2.7 
Total Gleason    
≤6 109 59.6 
7 60 32.8 
≥8 13 7.1 
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Table 3.  
 
 Positive 
surgical 
margin 
(N=30) 
Negative 
surgical 
margins 
(N=153) 
Odds 
ratio  
95% 
Confidenc
e interval 
Ptrend 
Pre-operative 
variables 
     
Age at surgery 
(yrs) 
    0.057 
≤60 19 (22%) 67 (78%) 1 Ref  
>60 11 (11%) 85 (89%) 0.46 0.20-1.02  
Date of 
Surgery 
    0.011 
2003-2004 13 (30%) 31 (70%) 1 Ref  
2005-2006 7 (15%) 41 (85%) 0.41 0.15-1.14  
2007-2009 10 (11%) 81 (89%) 0.29 0.12-0.74  
Ethnicity      0.052 
Black 9 28 1 Ref   
White 21 113 0.58 0.24-1.40  
Other 
+missing 
0 12 n/a n/a  
PSA (ng/ml) 
(SD) 
    0.093 
≤10 27 114 1 Ref  
>10 3 37 0.34 0.10-1.19  
Percentage 
cores positive 
(%)  
    0.720 
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<25% 8 (15%) 47 (85%) 1 Ref  
25-49% 10 (18%) 46 (82%) 1.28 0.46-3.52  
≥50% 8 (21%) 30 (79%) 1.57 0.53-4.62  
Missing 4  30 0.78 0.22-2.83  
Peri-operative 
variables 
     
Mean Blood 
Loss (mls) (SD) 
299.8 (363.7) 274.8 (185.4) 1.00 0.99-1.00 0.580 
Mean 
operative 
time (mins) 
(SD) 
160.8 (39.06) 158.0 (37.1) 1.00 0.99-1.01 0.708 
Nerve sparing 
status  
    0.219 
None 9 29 1 Ref  
Unilateral 4 25 0.52 0.14-1.88  
Bilateral 11 57 0.62 0.23-1.67  
Missing  6 42 0.46 0.23-3.47  
Post-
operative 
variables 
     
Mean 
Hospital stay 
(days) (SD) 
2.07 (1.2) 2.02 (2.26) 1.01 0.84-1.21 0.911 
Prostate 
Weight (g) 
    0.035 
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20-59 24 (24%) 76 (76%) 1 Ref  
60-99 3 (5%) 46 (95%) 0.21 0.06-0.72  
≥100 2 (15%)  11 (85%) 0.58 0.12-2.78  
Missing 1 20 0.16 0.02-1.24  
Pathologist      0.855 
1 10 57 1 Ref  
2 4 3 7.60 1.47- 
39.21 
 
3 1 9 0.63 0.07- 5.56  
4 11 42 1.49 0.58- 3.84  
5 0 9 n/a n/a  
6 0 1 n/a n/a  
7 3 8 2.14 0.48- 9.46  
8 0 1 n/a n/a  
9 1 4 1.43 0.14- 
14.10 
 
10 0 4 n/a n/a  
Surgical Stage 
(%) 
    0.035 
T2a 1  29 1 Ref  
T2b 12 40 8.70 1.07-
70.71 
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T2c 12 84 4.14 0.52-
33.27 
 
T2x 5 0 n/a n/a  
Total Gleason      0.187 
≤6 22 ( 87 1 Ref  
7 6 54 0.44 0.17-1.15  
≥8 2 11 0.72 0.15-3.48  
      
      
      
      
      
      
      
      
      
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 18 
Table 4.  
 
 Multivariable 
 OR 95% CI Ptrend 
Pre-operative variables    
Age at surgery (yrs)   0.042 
≤60 1 Ref  
>60 0.24 0.06-0.95  
Date of Surgery   0.018 
2003-2004 1 Ref  
2005-2006 0.44 0.04-5.22  
2007-2009 0.31 0.03-3.62  
Ethnicity   0.070 
Black 1 Ref  
White 0.71 0.19-2.70  
Other +missing n/a n/a n/a 
PSA (ng/ml)   0.131 
≤10 1 Ref  
>10 0.29 0.06-1.45  
Percentage cores 
positive (%) 
  0.898 
<25% 1 Ref  
25-49% 1.57 0.32-7.62  
≥50% 1.83 0.38-8.84  
Missing 0.97 0.13-7.19  
Peri-operative 
variables 
   
Blood Loss (mls) 1.00 0.99-1.00 0.576 
Op time (mins) 0.99 0.97-1.01 0.458 
Nerve sparing status   0.037 
 19 
None 1 Ref  
Unilateral 0.24 0.03-1.72  
Bilateral 0.19 0.04-1.00  
Missing 0.17 0.03-1.01  
Post-operative 
variables 
   
Surgical Stage    0.004 
T2a 1 Ref  
T2b  6.52 0.63-67.01  
T2c          7.52 0.50-113.26  
T2x n/a n/a  
Prostate weight (g)    0.031 
20-59 1 Ref  
60-99 0.35 0.08-1.52  
≥100 1.29 0.13-12.96  
Missing 0.16 0.02-1.64  
Total Gleason   0.148 
≤6 1 Ref  
7 0.18 0.04-0.90  
≥8 0.63 0.08-4.84  
Mean Hospital stay 
(days) 
0.88 0.63-1.21 0.427 
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Table 5.  
 
 Apex (%) 
N=15 
Circumferential 
(%) 
N=12 
Apex and 
circumferential 
(%) 
N=3 
P value 
Age at time of 
surgery (yrs)  
   0.898 
≤60 10 (62.5) 7 (58.3) 2 (66.7)  
>60 5 (31.3) 5 (41.7) 1 (33.3)  
Missing 1 (6.3) 0 (0.0) 0 (0.0)  
Ethnicity     0.924 
Black 4 (26.7) 4 (33.3) 1 (33.3)  
White 11 (73.3) 8 (66.7) 2 (66.7)  
Other 0 (0) 0 (0) 0 (0)  
Mean PSA (ng/ml)    0.189 
≤10 12 (80.0) 12 (100) 3 (100)  
>10 3 (20.0) 0 (0) 0 (0)  
Mean Percentage 
cores positive (%) 
   0.057 
<25% 0 (0) 7 (58.3) 1 (33.3)  
25-49% 7 (46.7) 2 (16.7) 1 (33.3)  
>50% 5 (33.3) 2 (16.7) 1 (33.3)  
Missing 3 (20.0) 1 (8.3) 0 (0)  
Mean Blood Loss 
(mls) (SD) 
182.33 (87.7) 300.83 (237.2) 883.33 (970.0) 0.006 
Mean operative 
time (mins) (SD) 
153 (34.4) 170.83 (45.9) 160 (34.6) 0.515 
Mean Hospital stay 
(days) (SD) 
2.27 (1.3) 1.67 (0.7) 2.67 (2.1) 0.297 
 21 
Mean Prostate 
Weight (g)  
   0.442 
20-59 12 (80.0) 10 (83.3) 2 (66.7)  
60-99 2 (13.3) 1 (8.3) 0 (0.0)  
≥100 0 (0.0) 1 (8.3) 1 (33.3)  
Missing 1 (6.7) 0 (0.0) 0 (0.0)  
Pathologist     0.144 
1 7 (30.4) 3 (15.8) 0 (0.0)  
2 1 (4.3) 2 (10.5) 1 (33.3)  
3 0 (0.0) 1 (5.3) 0 (0.0)  
4 5 (21.7) 5 (26.3) 1 (33.3)  
5 0 (0.0) 0 (0.0) 0 (0.0)  
6 0 (0.0) 0 (0.0) 0 (0.0)  
7 2 (8.7) 1 (5.3) 0 (0.0)  
8 0 (0.0) 0 (0.0) 0 (0.0)  
9 0 (0.0) 0 (0.0) 1 (33.3)  
10 0 (0.0) 0 (0.0) 0 (0.0)  
Missing=15 8 (34.8) 7 (36.8) 0 (0.0)  
Nerve sparing 
status 
   0.535 
None 3 (20.0) 5 (41.7) 1 (33.3)  
Unilateral 2 (13.3) 1 (8.3) 1 (33.3)  
Bilateral 5 (33.3) 5 (41,7) 1 (33.3)  
Missing 5 (33.3) 1 (8.3) 0 (0.0)  
Surgical Stage    0.010 
T2a 0 (0.0) 0 (0.0) 1 (33.3)  
T2b 4 (26.7) 8 (66.7) 0 (0.0)  
T2c 9 (60.0) 2 (16.7) 1 (33.3)  
 22 
T2x 2 (13.3) 2 (16.7) 1 (33.3)  
Total Gleason     0.626 
6 10 (62.5) 10 (83.3) 2 (66.7)  
7 3 (18.8) 2 (16.7) 1 (33.3)  
≥8 2 (12.5) 0 (0.0) 0 (0.0)  
Missing 1 (6.3) 0 (0.0) 0 (0.0)  
Date of Surgery     0.751 
2003-2004 5 (33.3) 7 (58.3) 1 (33.3)  
2005-2006 4 (26.7) 2 (16.7) 1 (33.3)  
2007-2009 6 (40.0) 3 (25.0) 1 (33.3)  
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